-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Intensity Therapeutics, Raises Price Target to $7

Benzinga·08/18/2026 17:40:32
語音播報
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Intensity Therapeutics (NASDAQ:INTS) with a Buy and raises the price target from $5 to $7.